S2 E10 - Inhaled steroids for COVID in GP; risk of COVID in adults with kids; 3 days of antibiotics for pneumonia; more semaglutide stuff
Big news in this new Hot Topics podcast as we discuss very positive data on the role of inhaled budesonide for early mild COVID in community-based patients - the STOIC trial may radically change our management of COVID but why hasn't this been a huge story and should we wait to change our practice?
Also, we look at a BMJ paper examining the risk of catching and dying from COVID if you are an adult with children at home, a Lancet paper looking at only 3 days of antibiotics for pneumonia and more data on semaglutide and it's role in weight loss and improvement in non-alcoholic steatohepatitis.
References:
STOIC website and pre-print
BMJ COVID and kids cohort study
Lancet Pneumonia trial
Lancet Semaglutide and weight loss in T2DM
NEJM Semaglutide and NASH
www.nbmedical.com/podcast
The podcast NB Hot Topics Podcast is embedded on this page from an open RSS feed. All files, descriptions, artwork and other metadata from the RSS-feed is the property of the podcast owner and not affiliated with or validated by Podplay.